NDAC 33-44-01-44

Compliance testing requirements for medical cannabinoid products

Last amended: 2019Year: 2026Length: 70 wordsOfficial source

Cite as N.D. Admin. Code ยง 33-44-01-44

A manufacturing facility shall have every process lot of a medical cannabinoid product, to be packaged in a container for transfer to a dispensary, tested for the following: 1. Pesticides and degradation compounds in accordance with section 33-44-01-47. 2. Microbiological contaminants and mycotoxins in accordance with section 33-44-01-48. 3. Heavy metals in accordance with section 33-44-01-48.1. 4. Solvents in accordance with section 33-44-01-49. 5. Concentration in accordance with section 33-44-01-51.
NDAC 33-44-01-44: Compliance testing requirements for medical cannabinoid products | Justis AI